%Responders to ADALIMUMAB in the cohort (WORLD):
by Thymidine Incorporation (95% CI): %19.0141 (15.493,22.77)
by IL-2 ELISpot (95% CI): %6.338 (4.2254,8.9202)
by Combined Thymidine Incorporation & IL-2 ELISpot (95% CI): %6.338 (4.2254,8.9202)
--
%Similarity between Thymidine Incorporation & IL-2 ELISpot predictions (95% CI): %87.3897 (84.1442,90.6351)
